Rockwell Medical Inc (RMTI)
1.49
-0.04
(-2.61%)
USD |
NASDAQ |
Apr 24, 16:00
1.47
-0.02
(-1.34%)
After-Hours: 20:00
Rockwell Medical Cash from Financing (TTM): 11.34M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 11.34M |
September 30, 2023 | 6.10M |
June 30, 2023 | -8.747M |
March 31, 2023 | 18.21M |
December 31, 2022 | 16.15M |
September 30, 2022 | 20.51M |
June 30, 2022 | 21.96M |
March 31, 2022 | -4.866M |
December 31, 2021 | -2.179M |
September 30, 2021 | -0.556M |
June 30, 2021 | 32.95M |
March 31, 2021 | 33.76M |
December 31, 2020 | 63.32M |
September 30, 2020 | 65.82M |
June 30, 2020 | 33.18M |
March 31, 2020 | 50.59M |
December 31, 2019 | 21.08M |
September 30, 2019 | 40.59M |
June 30, 2019 | 40.27M |
March 31, 2019 | 22.06M |
December 31, 2018 | 22.00M |
September 30, 2018 | 0.0055M |
June 30, 2018 | 0.1236M |
March 31, 2018 | -2.164M |
December 31, 2017 | -2.164M |
Date | Value |
---|---|
September 30, 2017 | -2.171M |
June 30, 2017 | -2.284M |
March 31, 2017 | 0.0029M |
December 31, 2016 | 0.0802M |
September 30, 2016 | -1.628M |
June 30, 2016 | -1.608M |
March 31, 2016 | -0.9743M |
December 31, 2015 | -0.1327M |
September 30, 2015 | 57.97M |
June 30, 2015 | 57.98M |
March 31, 2015 | 57.91M |
December 31, 2014 | 58.47M |
September 30, 2014 | 3.041M |
June 30, 2014 | 3.145M |
March 31, 2014 | 59.44M |
December 31, 2013 | 70.48M |
September 30, 2013 | 69.76M |
June 30, 2013 | 69.82M |
March 31, 2013 | 14.43M |
December 31, 2012 | 18.22M |
September 30, 2012 | 18.88M |
June 30, 2012 | 20.22M |
March 31, 2012 | 20.68M |
December 31, 2011 | 4.823M |
September 30, 2011 | 3.940M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-8.747M
Minimum
Jun 2023
65.82M
Maximum
Sep 2020
24.18M
Average
21.08M
Median
Dec 2019
Cash from Financing (TTM) Benchmarks
Cyclacel Pharmaceuticals Inc | 0.848M |
Oragenics Inc | 0.2839M |
Alpine Immune Sciences Inc | 165.12M |
Corvus Pharmaceuticals Inc | 7.855M |
MAIA Biotechnology Inc | 9.271M |